Jennifer Xu
Analyst
Cantor Fitzgerald
Equibles does not estimate personal net worth.
About Jennifer Xu
Jennifer Xu is recorded as Analyst at Cantor Fitzgerald. Jennifer Xu has spoken on 3 earnings calls across 3 companies, most recently for Arrowhead Pharmaceuticals, Inc. on August 4, 2026. Those appearances were for Arrowhead Pharmaceuticals, Inc. (ARWR), Ardelyx, Inc. (ARDX) and BlackRock, Inc. (BLK). The companies whose calls Jennifer Xu spoke on are classified in the Healthcare and Financial Services sectors.
Jennifer Xu on recent calls
“Just the first one is on Redemplo and SHTG. Just curious if you guys have a view on which TG responder analysis you view as maybe more important for establishing that Redemplo is a, you know, very strong TG lowering.”
“Can you talk about the IBSC market where you're finding the greatest opportunity, and what is driving the market growth of double-digit, and how long do you think it's sustainable?”
“At this time, I'd like to welcome everyone to the BlackRock Incorporated Fourth Quarter 2025 Earnings Teleconference. Our host for today's call will be Chairman and Chief Executive Officer Lawrence D. Think, Chief Financial Officer Martin S. Small, President Robert Escapito, and General Counsel Christopher J. Meade.”
Affiliation history
-
Cantor Fitzgerald
Analyst
Transcript header (unverified)
Current
Company network
Ardelyx, Inc.
ARDX
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-02-19
View calls and events
BlackRock, Inc.
BLK
Asset Management · Financial Services
1 appearance
Latest appearance 2026-01-15
View calls and events